Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis

Association Between HLA genotypes and Oxcarbazepine-induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-Analysis

(2018) Wimonchat Tangamornsuksan et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions

(2018) Wimonchat Tangamornsuksan et al.   JAMA Dermatology

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population

(2018) Taisei Mushiroda et al.   JAMA Neurology

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

(2018) Katie D. White et al.   Journal of Allergy and Clinical Immunology-In Practice

The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions

(2017) Patricia T. Illing et al.   IMMUNOGENETICS

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13

(2017) Therdpong Tempark et al.   Pharmacogenetics and Genomics

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2017) Elizabeth Noble Ergen et al.   JAMA Dermatology

HLAs: Key regulators of T-cell-mediated drug hypersensitivity

(2017) A. J. Redwood et al.   HLA

Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians

(2016) Chun-Bing Chen et al.   NEUROLOGY

Toxic Epidermal Necrolysis Induced by the Topical Carbonic Anhydrase Inhibitors Brinzolamide and Dorzolamide

(2016) Ji Sun Chun et al.   Annals of Dermatology

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update

(2015) Roni P. Dodiuk-Gad et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carryingHLA-B*59:01

(2015) Chang Shu et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans

(2015) Fangping Yang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS

Association of HLA-B*5701 Genotypes and Abacavir-Induced Hypersensitivity Reaction: A Systematic Review and Meta-Analysis

(2015) Wimonchat Tangamornsuksan et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

(2015) Thachanan Kongpan et al.   Pharmacogenetics and Genomics

Stevens–Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction

(2015) Sara Rufini et al.   PHARMACOGENOMICS

Toxic Epidermal Necrolysis in a Patient with HLA-B*5901 Haplotype Caused by Topical and Oral Carbonic Anhydrase Inhibitors

(2014) Minseok Cheon et al.   Annals of Dermatology

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

(2014) Faviel F. González-Galarza et al.   NUCLEIC ACIDS RESEARCH

Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population

(2014) Surasak Saokaew et al.   PLoS One

Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand

(2013) Somsak Tiamkao et al.   International Journal of Clinical Pharmacy

Relationship Between theHLA-B*1502Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2013) Wimonchat Tangamornsuksan et al.   JAMA Dermatology

Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

(2011) Ratchadaporn Somkrua et al.   BMC Medical Genetics

Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan

(2011) Pei Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toxic epidermal necrolysis and Stevens-Johnson syndrome

(2011) Thomas Harr et al.   Orphanet Journal of Rare Diseases

Genetics of early-onset obsessive–compulsive disorder

(2010) Susanne Walitza et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Stevens-Johnson syndrome induced by acetazolamide

(2010) Young HER et al.   JOURNAL OF DERMATOLOGY

Personalized medicine for HLA-associated drug-hypersensitivity reactions

(2010) Mandvi Bharadwaj et al.   Personalized Medicine

HLA-B*5901is strongly associated with methazolamide-induced Stevens–Johnson syndrome/toxic epidermal necrolysis

(2010) Sae-Hoon Kim et al.   PHARMACOGENOMICS

HLA phenotypes and bullous cutaneous reactions to drugs

(2010) Jean-Claude Roujeau et al.   TISSUE ANTIGENS

HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions

(2009) Hiroko Ikeda et al.   EPILEPSIA

Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles

(2009) Do Young KIM et al.   JOURNAL OF DERMATOLOGY

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics